Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,642 | 50 | 96.2% |
| Education | $105.50 | 1 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $500.35 | 5 | $0 (2024) |
| GENZYME CORPORATION | $499.43 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $349.85 | 5 | $0 (2024) |
| ABBVIE INC. | $270.38 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $267.15 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $180.04 | 5 | $0 (2024) |
| Orexo US, Inc. | $170.65 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $148.04 | 3 | $0 (2024) |
| CSL Behring | $125.00 | 1 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $71.01 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,308 | 33 | ABBVIE INC. ($270.38) |
| 2023 | $595.99 | 9 | GlaxoSmithKline, LLC. ($258.49) |
| 2022 | $722.90 | 8 | Novo Nordisk Inc ($233.76) |
| 2021 | $120.19 | 1 | Novo Nordisk Inc ($120.19) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Addiction Medicine | ||||||
| 11/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.37 | General |
| 11/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.29 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $105.50 | General |
| 11/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Central Nervous System | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $18.40 | General |
| Category: Addiction Medicine | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: VIROLOGY | ||||||
| 10/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Central Nervous System | ||||||
| 09/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.80 | General |
| 09/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: Addiction Medicine | ||||||
| 08/26/2024 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: Addiction Medicine | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Central Nervous System | ||||||
About Dr. Morgan Fox, DO
Dr. Morgan Fox, DO is a Addiction Medicine healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2021. The National Provider Identifier (NPI) number assigned to this provider is 1285208074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Morgan Fox, DO has received a total of $2,747 in payments from pharmaceutical and medical device companies, with $1,308 received in 2024. These payments were reported across 51 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,642).
Practice Information
- Specialty Addiction Medicine
- Location Livonia, MI
- Active Since 05/17/2021
- Last Updated 02/03/2025
- Taxonomy Code 207QA0401X
- Entity Type Individual
- NPI Number 1285208074
Products in Payments
- DUPIXENT (Biological) $499.43
- Zubsolv (Drug) $170.65
- Rybelsus (Drug) $146.37
- UBRELVY (Drug) $143.83
- CUVITRU (Biological) $125.00
- Hizentra (Biological) $125.00
- VRAYLAR (Drug) $124.99
- Wegovy (Drug) $124.99
- AIRSUPRA (Drug) $120.83
- RYBELSUS (Drug) $120.19
- Ozempic (Drug) $108.80
- AREXVY (Drug) $80.33
- Austedo XR (Drug) $74.54
- BEXSERO (Biological) $72.35
- CAPLYTA (Drug) $71.01
- MENVEO (Biological) $53.16
- REXULTI (Drug) $37.90
- FARXIGA (Drug) $27.21
- INGREZZA (Drug) $23.04
- XIFAXAN (Drug) $21.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.